| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of NCL mRNA | CTD | PMID:17557909 PMID:15576828 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of NCL mRNA | CTD | PMID:15576828 PMID:17557909 |
| 17beta-estradiol | increases expression | ISO | RGD:1342988 | 6480464 | Estradiol results in increased expression of NCL mRNA | CTD | PMID:16514628 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | ISO | RGD:1342988 | 6480464 | Metribolone promotes the reaction [NDRG1 protein binds to NCL protein] | CTD | PMID:17220478 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1553077 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NCL mRNA | CTD | PMID:20702594 PMID:16962184 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1553077 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NCL mRNA | CTD | PMID:16962184 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1553077 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NCL mRNA | CTD | PMID:16962184 PMID:20702594 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NCL protein | CTD | PMID:16548065 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of NCL mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of NCL mRNA | CTD | PMID:21346803 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1553077 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of NCL mRNA | CTD | PMID:18648102 |
| 4-vinylcyclohexene dioxide | affects expression | ISO | RGD:1553077 | 6480464 | 4-vinyl-1-cyclohexene dioxide affects the expression of NCL mRNA | CTD | PMID:20829426 |
| 5-fluorouracil | affects splicing | ISO | RGD:1342988 | 6480464 | Fluorouracil affects the splicing of NCL mRNA | CTD | PMID:17169984 |
| afimoxifene | decreases expression | ISO | RGD:1342988 | 6480464 | 4-hydroxytamoxifen results in decreased expression of NCL mRNA | CTD | PMID:16514628 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of NCL mRNA | CTD | PMID:20488242 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1342988 | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of NCL mRNA | CTD | PMID:15894607 |
| alpha-hexachlorocyclohexane | increases expression | EXP | | 6480464 | alpha-hexachlorocyclohexane results in increased expression of NCL mRNA | CTD | PMID:17785943 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of NCL mRNA | CTD | PMID:16483693 |
| amsacrine | affects response to substance | ISO | RGD:1342988 | 6480464 | NCL protein affects the susceptibility to Amsacrine | CTD | PMID:16600179 |
| arsenic atom | increases expression | ISO | RGD:1342988 | 6480464 | Arsenic results in increased expression of NCL protein | CTD | PMID:19818359 |
| arsenic trichloride | affects localization | ISO | RGD:1342988 | 6480464 | arsenic trichloride affects the localization of NCL protein | CTD | PMID:16421274 |
| arsenic trichloride | multiple interactions | ISO | RGD:1342988 | 6480464 | arsenic trichloride promotes the reaction [NCL protein binds to GADD45A mRNA] | CTD | PMID:16421274 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1553077 | 6480464 | Benzo(a)pyrene results in decreased expression of NCL mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:1553077 | 6480464 | Benzo(a)pyrene results in increased expression of NCL mRNA | CTD | PMID:22228805 |
| carbamazepine | decreases expression | EXP | | 6480464 | Carbamazepine results in decreased expression of NCL mRNA | CTD | PMID:17381134 |
| choline | multiple interactions | ISO | RGD:1553077 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NCL gene | CTD | PMID:20938992 |
| cisplatin | increases phosphorylation | ISO | RGD:1553077 | 6480464 | Cisplatin results in increased phosphorylation of NCL protein | CTD | PMID:22006019 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of NCL protein | CTD | PMID:22023808 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of NCL mRNA | CTD | PMID:17602206 |
| clozapine | increases expression | ISO | RGD:1553077 | 6480464 | Clozapine results in increased expression of NCL mRNA | CTD | PMID:14647396 |
| cobalt dichloride | decreases expression | ISO | RGD:1342988 | 6480464 | cobaltous chloride results in decreased expression of NCL mRNA | CTD | PMID:19376846 PMID:19320972 |
| cobalt dichloride | decreases expression | ISO | RGD:1342988 | 6480464 | cobaltous chloride results in decreased expression of NCL mRNA | CTD | PMID:19320972 PMID:19376846 |
| cyclosporin A | decreases expression | ISO | RGD:1553077 | 6480464 | Cyclosporine results in decreased expression of NCL mRNA | CTD | PMID:19770486 |
| cyclosporin A | decreases expression | ISO | RGD:1342988 | 6480464 | Cyclosporine results in decreased expression of NCL mRNA | CTD | PMID:22147139 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1342988 | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of NCL mRNA | CTD | PMID:15894607 |
| disodium selenite | increases expression | ISO | RGD:1342988 | 6480464 | Sodium Selenite results in increased expression of NCL mRNA | CTD | PMID:18175754 |
| ethanol | multiple interactions | EXP | | 6480464 | [Fish Oils co-treated with Ethanol] results in increased expression of NCL mRNA | CTD | PMID:17347304 |
| felbamate | decreases expression | EXP | | 6480464 | felbamate results in decreased expression of NCL mRNA | CTD | PMID:17381134 |
| folic acid | multiple interactions | ISO | RGD:1553077 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NCL gene | CTD | PMID:20938992 |
| fulvestrant | decreases expression | ISO | RGD:1342988 | 6480464 | fulvestrant results in decreased expression of NCL mRNA | CTD | PMID:16514628 |
| gabapentin | increases expression | EXP | | 6480464 | gabapentin results in increased expression of NCL mRNA | CTD | PMID:17381134 |
| haloperidol | increases expression | ISO | RGD:1553077 | 6480464 | Haloperidol results in increased expression of NCL mRNA | CTD | PMID:14647396 |
| hydrogen peroxide | affects expression | ISO | RGD:1342988 | 6480464 | Hydrogen Peroxide affects the expression of NCL mRNA | CTD | PMID:20044591 |
| L-methionine | multiple interactions | ISO | RGD:1553077 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NCL gene | CTD | PMID:20938992 |
| methoxychlor | affects expression | ISO | RGD:1553077 | 6480464 | Methoxychlor affects the expression of NCL mRNA | CTD | PMID:20829426 |
| paracetamol | affects expression | ISO | RGD:1553077 | 6480464 | Acetaminophen affects the expression of NCL mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:1342988 | 6480464 | Acetaminophen results in decreased expression of NCL mRNA | CTD | PMID:22230336 |
| paracetamol | increases expression | ISO | RGD:1342988 | 6480464 | Acetaminophen results in increased expression of NCL protein | CTD | PMID:22230336 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of NCL mRNA | CTD | PMID:19162173 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of NCL mRNA | CTD | PMID:17381134 |
| phenytoin | decreases expression | EXP | | 6480464 | Phenytoin results in decreased expression of NCL mRNA | CTD | PMID:17381134 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of NCL mRNA | CTD | PMID:19162173 |
| raloxifene | decreases expression | ISO | RGD:1342988 | 6480464 | Raloxifene results in decreased expression of NCL mRNA | CTD | PMID:16514628 |
| succimer | multiple interactions | ISO | RGD:1553077 | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NCL mRNA | CTD | PMID:21641980 |
| tetrachloromethane | affects expression | ISO | RGD:1553077 | 6480464 | Carbon Tetrachloride affects the expression of NCL mRNA | CTD | PMID:17484886 |
| trimellitic anhydride | increases expression | ISO | RGD:1553077 | 6480464 | trimellitic anhydride results in increased expression of NCL mRNA | CTD | PMID:19042947 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of NCL mRNA | CTD | PMID:17381134 |